PARP1 and neoplasm: DNA repair enzyme inhibition (e.g., PARP inhibition) may be prolonged in tumor tissues relative to normal tissues in vivo and recent data suggest that PARP inhibitors can “trap” the PARP1 and PARP2 enzymes at damaged DNA (137).